Abbott Laboratories (ABT) Social Stream



Abbott Laboratories (ABT): $114.01

0.37 (+0.33%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

B

ABBOTT LABORATORIES (ABT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ABBOTT LABORATORIES.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 14 $146 $125 $137.166 $110.98 23.6%
2021-12-10 15 $146 $125 $137.846 $110.98 24.21%
2021-12-22 14 $150 $125 $138.583 $110.98 24.87%
2022-01-24 14 $157 $125 $140.333 $110.98 26.45%
2022-01-27 13 $151 $125 $139.25 $110.98 25.47%
2022-04-11 14 $151 $125 $139.307 $110.98 25.52%
2022-04-14 14 $151 $125 $140.461 $110.98 26.56%
2022-05-18 10 $151 $125 $141.181 $110.98 27.21%
2022-06-07 10 $150 $125 $140.636 $110.98 26.72%
2022-06-13 10 $150 $125 $139.727 $110.98 25.9%
2022-07-22 12 $150 $95 $127.083 $110.98 14.51%
2022-09-28 13 $150 $95 $127.153 $110.98 14.57%
2022-10-05 13 $150 $95 $126.692 $110.98 14.16%
2022-10-11 15 $144 $95 $125.461 $110.98 13.05%
2022-10-12 15 $144 $95 $124.357 $110.98 12.05%
2022-10-18 15 $144 $95 $124.142 $110.98 11.86%
2022-10-21 16 $144 $95 $122.333 $110.98 10.23%
2022-12-05 16 $140 $95 $117.466 $110.98 5.84%
2022-12-12 16 $140 $95 $118 $110.98 6.33%
2023-01-04 16 $140 $95 $118.533 $110.98 6.81%
2023-01-06 16 $140 $95 $119.6 $110.98 7.77%
2023-01-23 15 $140 $95 $119.6 $110.98 7.77%
2023-01-25 15 $140 $95 $119.933 $110.98 8.07%
2023-01-27 16 $140 $95 $122.333 $110.98 10.23%
2023-03-28 16 $140 $95 $122.533 $110.98 10.41%
2023-04-05 16 $140 $95 $121.866 $110.98 9.81%
2023-04-17 16 $136 $95 $121.6 $110.98 9.57%
2023-04-20 18 $136 $103 $123.733 $110.98 11.49%
2023-05-16 18 $136 $103 $124.437 $110.98 12.13%
2023-07-13 18 $136 $103 $123.125 $110.98 10.94%
2023-07-21 18 $136 $103 $123.125 $110.98 10.94%
2023-07-24 18 $136 $103 $123.75 $110.98 11.51%
2023-09-08 18 $136 $103 $123.875 $110.98 11.62%
2023-10-02 18 $136 $103 $123.375 $110.98 11.17%
2023-10-10 18 $136 $103 $122.937 $110.98 10.77%
2023-10-17 18 $136 $103 $122.312 $110.98 10.21%
2023-10-19 18 $136 $103 $120.375 $110.98 8.47%
2023-12-06 18 $133 $103 $118.687 $110.98 6.94%
2023-12-13 18 $133 $103 $119 $110.98 7.23%
2023-12-21 18 $133 $103 $119.625 $110.98 7.79%

The Trend in the Analyst Price Target


Over the past 21 months, ABT's average price target has gone down $20.84.

ABT reports an average of 16.01% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 16 140 95 122.333 109.95 11.26%
2023-05-16 18 136 103 124.437 109.39 13.76%
2023-05-30 18 136 103 123.125 101.71 21.05%
2023-07-24 18 136 103 123.750 114.62 7.97%
2023-12-13 18 133 103 119.000 107.25 10.96%

ABT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.56 12 2 4 0 0 18

The Trend in the Broker Recommendations


ABT's average broker recommendation rating improved by 0.28 over the prior 30 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ABBOTT LABORATORIES's average analyst price target is higher than 4870.11% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ABBOTT LABORATORIES's number of analysts covering the stock is greater than 4798.48% of them.
  • ABT has a lower variance in analysts' estimates than -784.16% of Pharmaceutical Products stocks.
  • ABT has a higher upside potential (average analyst target price relative to current price) than 1098.22% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ABBOTT LABORATORIES are BNTX, MRNA, and GILD.

Make investment decisions regarding ABT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!